Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth fact...
Leadership
Andrew Oxtoby
President, CEO & Director
Srinivas Akkaraju M.D., Ph.D.Founder
Director & Co-Founder
Michael Philip Dybbs Ph.D.Founder
Co-Founder & Director
Napoleone Ferrara M.D.Founder
Independent Director & Co-Founder
Brett R. Hagen
Chief Accounting Officer and Principal Accounting & Financial Officer
